- Home
- SLI vs TERN Comparison
SLI vs TERN Comparison
Compare SLI & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLI
- TERN
- Stock Information
- Founded
- SLI 1998
- TERN 2017
- Country
- SLI Canada
- TERN United States
- Employees
- SLI N/A
- TERN N/A
- Industry
- SLI Major Chemicals
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- SLI Industrials
- TERN Health Care
- Exchange
- SLI Nasdaq
- TERN Nasdaq
- Market Cap
- SLI 595.8M
- TERN 634.5M
- IPO Year
- SLI N/A
- TERN 2021
- Fundamental
- Price
- SLI $2.92
- TERN $7.40
- Analyst Decision
- SLI Buy
- TERN Buy
- Analyst Count
- SLI 2
- TERN 6
- Target Price
- SLI $3.58
- TERN $13.99
- AVG Volume (30 Days)
- SLI 1.4M
- TERN 1.1M
- Earning Date
- SLI 11-11-2025
- TERN 11-11-2025
- Dividend Yield
- SLI N/A
- TERN N/A
- EPS Growth
- SLI N/A
- TERN N/A
- EPS
- SLI N/A
- TERN N/A
- Revenue
- SLI N/A
- TERN N/A
- Revenue This Year
- SLI N/A
- TERN N/A
- Revenue Next Year
- SLI N/A
- TERN N/A
- P/E Ratio
- SLI N/A
- TERN N/A
- Revenue Growth
- SLI N/A
- TERN N/A
- 52 Week Low
- SLI $1.08
- TERN $1.87
- 52 Week High
- SLI $3.13
- TERN $10.70
- Technical
- Relative Strength Index (RSI)
- SLI 53.66
- TERN 59.10
- Support Level
- SLI $2.77
- TERN $7.01
- Resistance Level
- SLI $3.11
- TERN $7.67
- Average True Range (ATR)
- SLI 0.16
- TERN 0.42
- MACD
- SLI -0.01
- TERN -0.06
- Stochastic Oscillator
- SLI 44.87
- TERN 62.00
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, and Bristol Dry Lake Project.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.